Versor Investments’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,700
Closed -$387K 890
2024
Q2
$387K Buy
+4,700
New +$345K 0.07% 431
2023
Q4
Sell
-10,059
Closed -$548K 793
2023
Q3
$548K Buy
+10,059
New +$596K 0.11% 274
2023
Q1
Sell
-4,500
Closed -$207K 806
2022
Q4
$207K Buy
+4,500
New +$211K 0.02% 624

Other funds holding LMAT

Versor Investments's LMAT Position: Q3 2024 in Review

Versor Investments sold out of LeMaitre Vascular (LMAT) in Q3 2024, closing a stake of 4,700 shares — an estimated $387K sold.

Versor Investments first reported a position in LMAT in Q4 2022 and held it in 3 quarters. The position peaked at $548K in Q3 2023. 291 funds tracked by Wall St. Rank hold LMAT as of Q3 2024.

  • Versor Investments reported no remaining LeMaitre Vascular position as of Q3 2024 after selling out during the quarter.
  • Versor Investments sold 4,700 LeMaitre Vascular shares in Q3 2024, an estimated $387K.
  • Versor Investments first reported a position in LeMaitre Vascular in Q4 2022 and held it in 3 quarters.
  • Versor Investments's LeMaitre Vascular position peaked at $548K in Q3 2023.
  • 291 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2024.

Based on Versor Investments's 13F filing for Q3 2024, filed 4 Nov 2024.